Corcept Therapeutics Incorporated shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $17M | 533k | 32.48 |
| 2023-09-30 | $11M | 409k | 27.25 |
| 2023-06-30 | $8.1M | 363k | 22.25 |
| 2023-03-31 | $8.7M | 403k | 21.66 |
| 2022-12-31 | $9.6M | 474k | 20.31 |
| 2022-06-30 | $7.3M | 309k | 23.78 |
| 2022-03-31 | $7.9M | 349k | 22.52 |
| 2021-12-31 | $7.3M | 368k | 19.80 |
| 2021-09-30 | $11M | 576k | 19.68 |
| 2021-03-31 | $12M | 484k | 23.79 |
| 2020-12-31 | $17M | 653k | 26.16 |
| 2020-09-30 | $8.3M | 477k | 17.41 |
| 2020-06-30 | $16M | 961k | 16.82 |
| 2019-12-31 | $5.6M | 464k | 12.10 |
| 2019-09-30 | $4.0M | 282k | 14.14 |
| 2019-06-30 | $2.4M | 214k | 11.15 |
| 2019-03-31 | $6.5M | 550k | 11.74 |
| 2018-12-31 | $7.7M | 580k | 13.37 |
| 2018-09-30 | $8.1M | 574k | 14.02 |
| 2018-06-30 | $13M | 839k | 15.72 |
| 2018-03-31 | $9.3M | 567k | 16.45 |
| 2017-12-31 | $12M | 677k | 18.06 |
| 2017-09-30 | $15M | 752k | 19.30 |
| 2017-06-30 | $3.2M | 273k | 11.80 |
| 2017-03-31 | $2.4M | 215k | 10.96 |
| 2016-12-31 | $959k | 132k | 7.25 |
| 2016-09-30 | $811k | 125k | 6.50 |
| 2016-06-30 | $332k | 61k | 5.47 |
| 2016-03-31 | $238k | 51k | 4.67 |
| 2015-12-31 | $244k | 49k | 4.97 |
| 2015-09-30 | $106k | 28k | 3.77 |
| 2015-06-30 | $211k | 35k | 6.02 |
| 2014-03-31 | $121k | 28k | 4.37 |
| 2013-12-31 | $70k | 22k | 3.21 |
| 2013-09-30 | $24k | 15k | 1.56 |
| 2013-03-31 | $24k | 12k | 2.03 |
| 2012-12-31 | $69k | 49k | 1.40 |
| 2012-09-30 | $60k | 21k | 2.79 |
| 2012-06-30 | $148k | 33k | 4.49 |
| 2012-03-31 | $449k | 114k | 3.93 |
| 2011-12-31 | $158k | 46k | 3.42 |
| 2011-09-30 | $59k | 19k | 3.10 |
| 2011-03-31 | $46k | 11k | 4.25 |
| 2010-12-31 | $177k | 46k | 3.86 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated